Neuralink has launched a patient registry.

To learn more about specific diseases to improve brain implantation. People with medical conditions such as tetraplegia or tetraparesis, paraplegia, visual loss, deafness, and aphasia can apply. This application may enable future clinical trials with Neuralink. The company expects to start conducting human trials in the first half of 2023, but it all depends on the FDA approval process.